ClinicalTrials.gg
Enrolling by invitationNCT07556211CHAINSPORTUpdated Apr 29, 2026

Neuromuscular Function and Performance in Athletes With or Without Bruxism

An observational study in Bruxism, sponsored by Mainjot Amélie. Enrolling by invitation at 1 site in Belgium. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-29.

Sponsored by Mainjot Amélie · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
120
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the associations between bruxism and neuromuscular function, as well as athletic performance, in a population of amateur athletes. Particular attention will be paid to musculoskeletal disorders associated with bruxism, particularly in the shoulder. Participants' history of sports injuries will also be recorded. To control for the effect of potential confounding variables, levels of stress, anxiety, and mood, as well as sleep quality, will be systematically measured using validated questionnaires.

02

Conditions studied

  • Bruxism

Browse trials for

03

In context

Bruxism

151 studies on the registry are indexed under Bruxism; 39 are open to participants now.

This study's planned enrollment of 120 is above the median of 89 across 55 observational studies indexed under Bruxism.

Browse Bruxism studies →

Lead sponsor

Mainjot Amélie is the lead sponsor of 3 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Amateur athletes from the Province of Liège

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Practices swimming or handball 3 to 8 hours per week.
  • Has the cognitive/mental capacity to take part in this study.
  • Fluent in the language of the survey (French).

Exclusion criteria

Exclusion Criteria:

  • Current orthodontic treatment or treatment completed within the last 2 months.
  • Shoulder and/or cervical spine injury or surgery within the past 6 months.
  • Current cessation or limitation of sports activity due to shoulder and/or cervical symptoms at the time of participation.
  • Any pathology or history of trauma to the dominant hand resulting in reduced grip strength.
  • Any clinically manifest infectious episode at the time of participation.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • athlete

    amateur athletes in the Province of Liège, aged between 18 and 35

06

What researchers measure

Primary outcomes

  1. Muscular Tone

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest, The device gives : F - Natural Oscillation Frequency \[Hz\], characterizing Tone or Tension (higher values = higher tension)

    Time frame: Baseline

  2. Dynamic Stiffness

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest, The device gives : S - Dynamic Stiffness \[N/m\] (This biophysical parameter reflects the muscle's ability to resist contractions or external stresses to deformation, it can increased with exercice or pain)

    Time frame: Baseline

  3. Muscular elasticity

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest, The device gives parameter of the neuromuscular function: D - Logarithmic Decrement \[relative unit\], characterizing Elasticity (Higher values = lower elasticity)

    Time frame: Baseline

  4. Muscular Mechanical Stress Relaxation Time

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest, The device gives : R - Mechanical Stress Relaxation Time \[ms\] (low value correspond to fast tissue recovers its shape)

    Time frame: Baseline

  5. Muscular Creep

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest, The device gives : C - Ratio of Relaxation and Deformation time \[relative unit\], characterizing Creep (Higher Creep Value: Indicates higher fluidity, meaning the muscle is less rigid)

    Time frame: Baseline

  6. Maximal grip strength test

    Will be evaluated with the Eforto device, which is the first validated device to measure maximal grip strength test. One value in kPa. Higher values indicate higher muscle strength.

    Time frame: Baseline

  7. Muscle fatigue

    Will be evaluated with the Eforto device, which is the first validated device to measure muscle fatigability (fatigue resistance test, which was shown to reflect the level of both muscle energy and metabolism, neuromuscular function, and immune and stress responses). One value obtained, in seconds. Cut-off normative values in healthy 25-35 year-old male and female people are available, and lower values indicate increased muscle fatigability.

    Time frame: Baseline

  8. Trapeze isometric force

    Will be evaluated with dynamometer, higher values (unit is N) meaning higher muscular isometric force

    Time frame: Baseline

  9. Muscular Tone

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest, The device gives : F - Natural Oscillation Frequency \[Hz\], characterizing Tone or Tension (higher values = higher tension)

    Time frame: 15-30 minutes after training

  10. Dynamic Stiffness

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest, The device gives : S - Dynamic Stiffness \[N/m\] (This biophysical parameter reflects the muscle's ability to resist contractions or external stresses to deformation, it can increased with exercice or pain)

    Time frame: 15-30 minutes after training

  11. Muscular elasticity

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest, The device gives parameter of the neuromuscular function: D - Logarithmic Decrement \[relative unit\], characterizing Elasticity (Higher values = lower elasticity)

    Time frame: 15-30 minutes after training

  12. Muscular Mechanical Stress Relaxation Time

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest, The device gives : R - Mechanical Stress Relaxation Time \[ms\] (low value correspond to fast tissue recovers its shape)

    Time frame: 15-30 minutes after training

  13. Muscular Creep

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest, The device gives : C - Ratio of Relaxation and Deformation time \[relative unit\], characterizing Creep (Higher Creep Value: Indicates higher fluidity, meaning the muscle is less rigid)

    Time frame: 15-30 minutes after training

Secondary outcomes

  1. Shoulder - passive range of motion

    Measurement of passive range of motion in internal and external rotation of the shoulder using a goniometer (in degrees), with the arm abducted 90° in the frontal plane. The higher values correspond to the higher passive range of motion

    Time frame: Baseline

  2. Cervical spine mobility

    Cervical spine mobility (flexion, extension, lateral flexion to the right and left, and rotation to the right and left). Assessment using a ordinal scale with values : Good, limited, very limited, from better to worse outcomes.

    Time frame: Baseline

  3. Athletic performance

    Athletic performance will be assessed and measured at the start of training and after the warm-up using a test specific to each sport. For swimmers, a 50-meter crawl at maximum speed will be timed. For handball players, a T-test will be conducted and measured using photoelectric sensors. This test evaluates speed and accuracy on a course of cones arranged in a T-shape with specific distances between the cones (spaced 5 to 10 meters apart). The lower values correspond to the better athletic performance.

    Time frame: Baseline

  4. History of sports injuries

    Obtained through questioning following International Olympic Committee guidelines. Descriptive outcome. Score severity according to the number and the severity of the injuries.

    Time frame: Baseline

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07556211
Lead sponsor
Mainjot Amélie
Responsible party
Mainjot Amélie (Professor, University of Liege) — Sponsor-investigator
First posted
Apr 29, 2026
Start date
Aug 1, 2026 (estimated)
Primary completion
Jul 1, 2028 (estimated)
Completion
Jul 1, 2028 (estimated)
Last update
Apr 29, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion